AACR 2025 Poster Presentation: Ficerafusp Alfa Reverses Acquired Resistance to the KRAS-G12C Inhibitor, Sotorasib in KRAS-G12C-Mutated Lung Tumors

Bicara Therapeutics Inc. published this content on April 28, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 02, 2025 at 10:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]